Hartline Investment Corp Makes New $1.64 Million Investment in SPDR S&P Biotech ETF $XBI

Hartline Investment Corp purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 13,437 shares of the exchange traded fund’s stock, valued at approximately $1,638,000.

A number of other large investors also recently made changes to their positions in XBI. Legacy Wealth Managment LLC ID purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth $32,000. Ballast Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth $36,000. Creative Financial Designs Inc. ADV purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth $39,000. Barnes Dennig Private Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth $48,000. Finally, Navalign LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth $48,000.

SPDR S&P Biotech ETF Stock Down 0.8%

Shares of SPDR S&P Biotech ETF stock opened at $131.66 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $78.00 and a fifty-two week high of $139.19. The firm has a market cap of $8.40 billion, a PE ratio of 11.47 and a beta of 0.85. The business’s fifty day moving average is $129.82 and its two-hundred day moving average is $125.05.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.